Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Kymera Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 164
- +28 vs. Q4 2023
- Shares held
- 67.2M
- +6.80M (+11.2%) vs. Q4 2023
- Total value
- $2.70B
- +$1.16B (+75.6%) vs. Q4 2023
- New holders
- 41
- 60 more added
- Sold out
- 13
- 44 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | 51,757 | $2.08M | 0.00% | +2,646+5.4% | Added |
| Millennium Management LLC | 53,052 | $2.13M | 0.00% | −45,244−46.0% | Reduced |
| Propel Bio Management, LLC | 56,359 | $2.27M | 1.32% | 00.0% | Unchanged |
| Rhumbline Advisers | 57,392 | $2.31M | 0.00% | +3,889+7.3% | Added |
| First Trust Advisors LP | 67,742 | $2.72M | 0.00% | +67,742 | New |
| D. E. Shaw & Co., Inc. | 67,762 | $2.72M | 0.00% | +67,762 | New |
| Voya Investment Management LLC | 70,440 | $2.83M | 0.00% | −2,534−3.5% | Reduced |
| Susquehanna Fundamental Investments, LLC | 71,493 | $2.87M | 0.13% | +71,493 | New |
| Swiss National Bank | 79,700 | $3.20M | 0.00% | +8,700+12.3% | Added |
| Squarepoint Ops LLC | 85,251 | $3.43M | 0.01% | +57,053+202.3% | Added |
| Nuveen Asset Management, LLC | 95,995 | $3.86M | 0.00% | −40,831−29.8% | Reduced |
| Atika Capital Management LLC | 102,000 | $4.10M | 0.46% | +102,000 | New |
| Alliancebernstein L.P. | 102,103 | $4.10M | 0.00% | +63,703+165.9% | Added |
| AXA S.A. | 109,217 | $4.39M | 0.01% | +109,217 | New |
| Invesco Ltd. | 113,367 | $4.56M | 0.00% | +85,278+303.6% | Added |
| Manufacturers Life Insurance Company, The | 114,757 | $4.61M | 0.00% | +14,684+14.7% | Added |
| Norges Bank | 117,883 | $4.74M | 0.00% | −386,200−76.6% | Reduced |
| Schroder Investment Management Group | 120,847 | $4.86M | 0.01% | −64,452−34.8% | Reduced |
| Neuberger Berman Group LLC | 125,179 | $5.03M | 0.00% | +4,100+3.4% | Added |
| Two Sigma Investments, LP | 127,746 | $5.14M | 0.01% | −4,818−3.6% | Reduced |
| Bank of New York Mellon Corp | 130,894 | $5.26M | 0.00% | −2,697−2.0% | Reduced |
| Gilder Gagnon Howe & Co LLC | 132,989 | $5.35M | 0.07% | +132,989 | New |
| Great Lakes Advisors, LLC | 156,377 | $6.29M | 0.05% | +156,377 | New |
| Trexquant Investment LP | 162,115 | $6.52M | 0.13% | −41,449−20.4% | Reduced |
| Bank of America Corp | 162,291 | $6.52M | 0.00% | +132,293+441.0% | Added |
| UBS Asset Management Americas Inc | 179,938 | $7.23M | 0.00% | +3,438+1.9% | Added |
| Two Sigma Advisers, LP | 209,100 | $8.41M | 0.02% | +38,200+22.4% | Added |
| Rafferty Asset Management, LLC | 210,861 | $8.48M | 0.03% | +90,672+75.4% | Added |
| TD Asset Management Inc | 218,804 | $8.80M | 0.01% | +32,322+17.3% | Added |
| Citigroup Inc | 220,911 | $8.88M | 0.01% | +131,982+148.4% | Added |
| Credit Suisse AG | 227,586 | $9.15M | 0.01% | +63,434+38.6% | Added |
| Citadel Advisors LLC | 261,381 | $10.5M | 0.01% | −110,062−29.6% | Reduced |
| Voloridge Investment Management, LLC | 267,514 | $10.8M | 0.04% | +25,716+10.6% | Added |
| UBS Group AG | 296,680 | $11.9M | 0.00% | −3,783−1.3% | Reduced |
| Barclays PLC | 319,901 | $12.9M | 0.01% | −61,880−16.2% | Reduced |
| Candriam Luxembourg S.C.A. | 328,302 | $13.2M | 0.08% | −15,000−4.4% | Reduced |
| Dimensional Fund Advisors LP | 349,209 | $14.0M | 0.00% | −184,514−34.6% | Reduced |
| Charles Schwab Investment Management Inc | 354,106 | $14.2M | 0.00% | +47,414+15.5% | Added |
| Northern Trust Corp | 372,786 | $15.0M | 0.00% | +14,207+4.0% | Added |
| Schonfeld Strategic Advisors LLC | 380,442 | $15.3M | 0.12% | −57,191−13.1% | Reduced |
| Aquilo Capital Management, LLC | 388,743 | $15.6M | 11.71% | −492,594−55.9% | Reduced |
| Massachusetts Financial Services Co | 395,139 | $15.9M | 0.00% | −67,536−14.6% | Reduced |
| Deer Management Co. LLC | 415,895 | $16.7M | 3.03% | −200,000−32.5% | Reduced |
| Jennison Associates LLC | 425,920 | $17.1M | 0.01% | +425,920 | New |
| Goldman Sachs Group Inc | 450,518 | $18.1M | 0.00% | −224,137−33.2% | Reduced |
| JPMorgan Chase & Co | 455,936 | $18.3M | 0.00% | −56,310−11.0% | Reduced |
| Woodline Partners LP | 500,930 | $20.1M | 0.19% | +400,179+397.2% | Added |
| Morgan Stanley | 547,140 | $22.0M | 0.00% | +105,862+24.0% | Added |
| Marshall Wace, LLP | 572,926 | $23.0M | 0.04% | +572,926 | New |
| Geode Capital Management, LLC | 965,700 | $38.8M | 0.00% | +85,185+9.7% | Added |
| Deep Track Capital, LP | 1,262,246 | $50.7M | 1.46% | +1,262,246 | New |
| Rock Springs Capital Management LP | 1,522,238 | $61.2M | 1.56% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,734,089 | $69.7M | 2.56% | −89,867−4.9% | Reduced |
| State Street Corp | 2,672,518 | $107.4M | 0.00% | +778,239+41.1% | Added |
| Artal Group S.A. | 3,027,135 | $121.7M | 3.14% | +496,400+19.6% | Added |
| BlackRock Inc. | 3,655,660 | $147.0M | 0.00% | +89,049+2.5% | Added |
| Avoro Capital Advisors LLC | 3,888,888 | $156.3M | 1.82% | +113,888+3.0% | Added |
| Wellington Management Group LLP | 4,293,697 | $172.6M | 0.03% | −521,861−10.8% | Reduced |
| FMR LLC | 4,364,410 | $175.4M | 0.01% | +3,829,810+716.4% | Added |
| Vanguard Group Inc | 4,767,050 | $191.6M | 0.00% | +769,486+19.2% | Added |
| BVF Inc | 5,161,801 | $207.5M | 5.70% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,377,362 | $216.2M | 19.95% | −480,900−8.2% | Reduced |
| Baker Bros. Advisors LP | 5,995,928 | $241.0M | 3.02% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 6,332,012 | $254.5M | 0.03% | +996,300+18.7% | Added |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,295,943−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −107,307−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −95,580−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −40,207−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −24,629−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −22,677−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −14,208−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,566−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −10,806−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −9,162−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −8,135−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −6,893−100.0% | Sold out |
| Avalon Trust Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| AtonRa Partners | – | – | – | – | Not filed |